Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,355,395
-$712,071 QoQ
Shares Held
149,538
+1.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#197
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. AZN ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
212,458 | $254,828,520 | |
| 2 | JNJ |
Johnson & Johnson
|
550,760 | $139,876,517 | |
| 3 | ABBV |
AbbVie Inc.
|
409,814 | $103,125,594 | |
| 4 | MRK |
Merck & Co., Inc.
|
565,110 | $72,616,635 | |
| 5 | AMGN |
Amgen Inc
|
138,472 | $50,143,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
284,053 | $35,887,256 | |
| 7 | PFE |
Pfizer Inc
|
1,303,824 | $31,396,081 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
149,538 | $28,355,395 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,355,395 | 149,538 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,067,466 | 147,386 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||